As a multinational pharmaceutical company, we are guided by our purpose to accelerate access to affordable and innovative medicines, because we believe that “Good Health Can’t Wait”. This credo unites over 24000 employees worldwide. We aspire to provide a culture of empathy and dynamism that allows us to understand the needs of our patients and partners. Today millions of patients in over 66 countries have access to Dr. Reddy’s products.

Our goal is always to ensure Good Health. For us, drugs are not just molecules, but tools that help patients heal. Can’t wait reflects our commitment to act quickly to find innovative solutions that address patients’ unmet needs and accelerate access to much-needed medicines for people around the world.

Since our establishment in 2002, we have supported UK’s healthcare system with our affordable prescription and OTC medicines portfolio. Our presence in the UK includes commercial offices in Cambridge, an R&D center in Cambridge, and an Active Pharmaceutical Ingredient (API) manufacturing site in Mirfield.

We work closely with the country’s healthcare partners to ensure that our medicines are available where needed. Our commitment to providing good health includes patients and the planet. As a PSCI (Pharmaceutical Supply Chain Initiative) member, we actively support the core principles of human rights, ethics, human rights and labor, health and safety, environment, and management systems. Since 2006, we are listed as one of the most sustainable pharmaceutical companies by the Dow Jones Sustainability Indices (DJSI).